|
MechanismCTNNB inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Erzincan Binali Yıldırım University
0 Patents (Medical) associated with Erzincan Binali Yıldırım University
100 Deals associated with Erzincan Binali Yıldırım University
100 Translational Medicine associated with Erzincan Binali Yıldırım University